Search Results - "BREWSTER, Abenaa M"

Epidemiology, biology, and treatment of triple-negative breast cancer in women of African ancestry by Brewster, Abenaa M, Dr, Chavez-MacGregor, Mariana, MD, Brown, Powel, Prof

“…Summary Breast cancer incidence is increasing worldwide, and breast cancer-related mortality is highest in women of African ancestry, who are more likely to…”
Get full text

Alcohol and Cancer: A Statement of the American Society of Clinical Oncology by LoConte, Noelle K, Brewster, Abenaa M, Kaur, Judith S, Merrill, Janette K, Alberg, Anthony J

“…Alcohol drinking is an established risk factor for several malignancies, and it is a potentially modifiable risk factor for cancer. The Cancer Prevention…”
Get full text

Clinical factors associated with adherence to aerobic and resistance physical activity guidelines among cancer prevention patients and survivors by Coletta, Adriana M, Marquez, Guillermo, Thomas, Parijatham, Thoman, Whittney, Bevers, Therese, Brewster, Abenaa M, Hawk, Ernest, Basen-Engquist, Karen, Gilchrist, Susan C

“…Physical activity (PA) is a known behavior to reduce cancer risk and improve cancer survivorship, yet adherence to PA guidelines is poor among the general…”
Get full text

Feasibility and efficacy of a weight gain prevention intervention for breast cancer patients receiving neoadjuvant chemotherapy: a randomized controlled pilot study by Basen-Engquist, Karen M., Raber, Margaret, Carmack, Cindy L., Arun, Banu, Brewster, Abenaa M., Fingeret, Michelle, Schembre, Susan M., Harrison, Carol, Perkins, Heidi Y, Li, Yisheng, Song, Jaejoon, Chen, Minxing, Murray, James L.

“…Purpose Weight gain is common among breast cancer patients and may contribute to poorer treatment outcomes. Most programs target breast cancer survivors after…”
Get full text

Relationship Between Obesity and Pathologic Response to Neoadjuvant Chemotherapy Among Women With Operable Breast Cancer by LITTON, Jennifer K, GONZALEZ-ANGULO, Ana M, WARNEKE, Carla L, BUZDAR, Aman U, KAU, Shu-Wan, BONDY, Melissa, MAHABIR, Somdat, HORTOBAGYI, Gabriel N, BREWSTER, Abenaa M

“…To understand the mechanism through which obesity in breast cancer patients is associated with poorer outcome, we evaluated body mass index (BMI) and response…”
Get full text

Salutary effects of moderate but not high intensity aerobic exercise training on the frequency of peripheral T-cells associated with immunosenescence in older women at high risk of breast cancer: a randomized controlled trial by Niemiro, Grace M, Coletta, Adriana M, Agha, Nadia H, Mylabathula, Preteesh Leo, Baker, Forrest L, Brewster, Abenaa M, Bevers, Therese B, Fuentes-Mattei, Enrique, Basen-Engquist, Karen, Katsanis, Emmanuel, Gilchrist, Susan C, Simpson, Richard J

“…Immunosenescence is described as age-associated changes within the immune system that are responsible for decreased immunity and increased cancer risk…”
Get full text

Ductal Carcinoma in Situ: State of the Science and Roadmap to Advance the Field by KUERER, Henry M, ALBARRACIN, Constance T, BABIERA, Gildy, EDGERTON, Mary E, CZERNIECKI, Brian J, ARUN, Banu K, HORTOBAGYI, Gabriel N, YANG, Wei T, CARDIFF, Robert D, BREWSTER, Abenaa M, FRASER SYMMANS, W, HYLTON, Nola M, MIDDLETON, Lavinia P, KRISHNAMURTHY, Savitri, PERKINS, George H

“…Ductal carcinoma in situ (DCIS) is the fourth leading cancer for women in the United States. Understanding of the biology and clinical behavior of DCIS is…”
Get full text

Correction: Salutary effects of moderate but not high intensity aerobic exercise training on the frequency of peripheral T-cells associated with immunosenescence in older women at high risk of breast cancer: a randomized controlled trial by Niemiro, Grace M, Coletta, Adriana M, Agha, Nadia H, Mylabathula, Preteesh Leo, Baker, Forrest L, Brewster, Abenaa M, Bevers, Therese B, Fuentes-Mattei, Enrique, Basen-Engquist, Karen, Katsanis, Emmanuel, Gilchrist, Susan C, Simpson, Richard J

Get full text

Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies by Pande, Mala, Joon, Aron, Brewster, Abenaa M, Chen, Wei V, Hopper, John L, Eng, Cathy, Shete, Sanjay, Casey, Graham, Schumacher, Fredrick, Lin, Yi, Harrison, Tabitha A, White, Emily, Ahsan, Habibul, Andrulis, Irene L, Whittemore, Alice S, John, Esther M, Ko Win, Aung, Makalic, Enes, Schmidt, Daniel F, Kapuscinski, Miroslaw K, Ochs-Balcom, Heather M, Gallinger, Steven, Jenkins, Mark A, Newcomb, Polly A, Lindor, Noralane M, Peters, Ulrike, Amos, Christopher I, Lynch, Patrick M

“…Clustering of breast and colorectal cancer has been observed within some families and cannot be explained by chance or known high-risk mutations in major…”
Get full text

Phase III Trial Evaluating Weekly Paclitaxel Versus Docetaxel in Combination With Capecitabine in Operable Breast Cancer by KELLY, Catherine M, GREEN, Marjorie C, HUNT, Kelly K, HORTOBAGYI, Gabriel N, BUZDAR, Aman U, BROGLIO, Kristine, THOMAS, Eva S, BREWSTER, Abenaa M, VALERO, Vicente, IBRAHIM, Nuhad K, GONZALEZ-ANGULO, Ana M, BOOSER, Daniel J, WALTERS, Ronald S

“…We investigated whether capecitabine and docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide (FEC) or weekly paclitaxel (WP) followed by FEC…”
Get full text

Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype by Symmans, W Fraser, Wei, Caimiao, Gould, Rebekah, Yu, Xian, Zhang, Ya, Liu, Mei, Walls, Andrew, Bousamra, Alex, Ramineni, Maheshwari, Sinn, Bruno, Hunt, Kelly, Buchholz, Thomas A, Valero, Vicente, Buzdar, Aman U, Yang, Wei, Brewster, Abenaa M, Moulder, Stacy, Pusztai, Lajos, Hatzis, Christos, Hortobagyi, Gabriel N

“…Purpose To determine the long-term prognosis in each phenotypic subset of breast cancer related to residual cancer burden (RCB) after neoadjuvant chemotherapy…”
Get full text

Selective genomic copy number imbalances and probability of recurrence in early-stage breast cancer by Thompson, Patricia A, Brewster, Abenaa M, Kim-Anh, Do, Baladandayuthapani, Veerabhadran, Broom, Bradley M, Edgerton, Mary E, Hahn, Karin M, Murray, James L, Sahin, Aysegul, Tsavachidis, Spyros, Wang, Yuker, Zhang, Li, Hortobagyi, Gabriel N, Mills, Gordon B, Bondy, Melissa L

“…A number of studies of copy number imbalances (CNIs) in breast tumors support associations between individual CNIs and patient outcomes. However, no pattern or…”
Get full text

Cardiovascular Prevention Strategies in Breast Cancer by Yin, Alexandra B., Brewster, Abenaa M., Barac, Ana, Thoman, Whittney, Oeffinger, Kevin C., Gilchrist, Susan C.

Get full text

Phase I/II Study of G3139 (Bcl-2 Antisense Oligonucleotide) in Combination with Doxorubicin and Docetaxel in Breast Cancer by MOULDER, Stacy L, FRASER SYMMANS, W, ZWIEBEL, James, VALERO, Vicente, HORTOBAGYI, Gabriel N, ESTEVA, Francisco J, BOOSER, Daniel J, MADDEN, Timothy L, LIPSANEN, Cindy, LINDA YUAN, BREWSTER, Abenaa M, CRISTOFANILLI, Massimo, HUNT, Kelly K, BUCHHOLZ, Thomas A

“…Purpose: Preclinical data showed enhancement of breast cancer cell death when G3139 was combined with anthracyclines and taxanes. We evaluated the efficacy and…”
Get full text

Randomized Trial of Adjuvant 13-cis-Retinoic Acid and Interferon Alfa for Patients With Aggressive Skin Squamous Cell Carcinoma by Brewster, Abenaa M, Lee, J Jack, Clayman, Gary L, Clifford, John L, Reyes, Mary Jo T Necesito, Zhou, Xian, Sabichi, Anita L, Strom, Sara S, Collins, Robert, Meyers, Christina A, Lippman, Scott M

“…To conduct a phase III trial of adjuvant 13-cis-retinoic acid (13cRA) plus interferon alfa (IFN-alpha) for preventing tumor recurrence and second primary…”
Get full text

Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update by Visvanathan, Kala, Fabian, Carol J, Bantug, Elissa, Brewster, Abenaa M, Davidson, Nancy E, DeCensi, Andrea, Floyd, Justin D, Garber, Judy E, Hofstatter, Erin W, Khan, Seema A, Katapodi, Maria C, Pruthi, Sandhya, Raab, Rachal, Runowicz, Carolyn D, Somerfield, Mark R

“…To update the ASCO guideline on pharmacologic interventions for breast cancer risk reduction and provide guidance on clinical issues that arise when deciding…”
Get full text

Neoadjuvant Talazoparib for Patients With Operable Breast Cancer With a Germline BRCA Pathogenic Variant by Litton, Jennifer K, Scoggins, Marion E, Hess, Kenneth R, Adrada, Beatriz E, Murthy, Rashmi K, Damodaran, Senthil, DeSnyder, Sarah M, Brewster, Abenaa M, Barcenas, Carlos H, Valero, Vicente, Whitman, Gary J, Schwartz-Gomez, Jill, Mittendorf, Elizabeth A, Thompson, Alastair M, Helgason, Thorunn, Ibrahim, Nuhad, Piwnica-Worms, Helen, Moulder, Stacy L, Arun, Banu K

“…Talazoparib has demonstrated efficacy in patients with -positive metastatic breast cancer. This study evaluated the pathologic response of talazoparib alone…”
Get full text

Who should get a contralateral prophylactic mastectomy for breast cancer? by Bedrosian, Isabelle, Parker, Patricia A., Brewster, Abenaa M.

Get full text

Relationship Between Epidemiologic Risk Factors and Breast Cancer Recurrence by BREWSTER, Abenaa M, DO, Kim-Anh, THOMPSON, Patricia A, HAHN, Karin M, SAHIN, Aysegul A, YUMEI CAO, STEWART, Maureen M, MURRAY, James L, HORTOBAGYI, Gabriel N, BONDY, Melissa L

“…Early-stage breast cancers are biologically heterogeneous and vary in clinical behavior, supporting the role of factors other than tumor size and lymph node…”
Get full text

Racial/ethnic disparities in use of surveillance mammogram among breast cancer survivors: a systematic review by Advani, Pragati, Advani, Shailesh, Nayak, Pratibha, VonVille, Helena M., Diamond, Pamela, Burnett, Jason, Brewster, Abenaa M., Vernon, Sally W.

“…Background Increasing number of breast cancer survivors in the USA have led to greater focus on the long-term health outcomes and surveillance care among these…”
Get full text